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Case Report
CAS E R E PORT
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Abstract
A 29-year-old male, with chronic atopic dermatitis (AD), presented with a 2-week history of fatigue, pyrexia and weight loss.
Examination showed eczematous patches with lichenified papules, erosions on the right shin and a new murmur. Blood
cultures isolated methicillin-sensitive Staphylococcus aureus. Transthoracic echocardiography showed vegetation on the
tricuspid valve (TV) that was adherent to the septal leaflet. He was treated for infective endocarditis, attributed to poorly
controlled AD, with intravenous Flucloxacillin. Due to ongoing sepsis and pulmonary septic emboli, Clindamycin was added.
He underwent TV repair; the septal leaflet was excised, and the remnant two leaflets were brought together with a ring. His
patent foramen ovale was closed. His skin was treated with topical steroids and emollients. Right-sided endocarditis of an
intact TV is uncommon in a non-intravenous drug user. Therefore, this novel case portrays the importance of aggressively
managing AD as it is a risk factor for significant systemic infections.
INTRODUCTION
Atopic dermatitis (AD) affects 1–3% of the population and is
seen in all age groups. Antimicrobial, antifungal and antiviral
peptides, induced by inflammation, are deficient in patients
with atopic dermatitis, and there is skin colonisation by Staphy-
lococcus aureus in more than 90% of patients. This increases the
risk of invasion of bacteria through the interrupted skin barrier,
subsequently promoting bacteraemia and extracutaneous infec-
tions including endocarditis, meningitis, encephalitis, bone and
joint infections and sepsis [1–5]. We discuss a case of infective
endocarditis in a 29-year-old male with AD and no history of
recreational drug use.
CASE REPORT
A 29-year-old male presented with a 2-week history of fatigue,
headache, fever and weight loss. He had AD since childhood
with recurrent exacerbations that weremanaged topically by his
general practitioner. He was not on regular medications and had
no known drug allergies, but he had a history of hay fever and
family history of atopy. He never smoked, did not drink alcohol
and had never used recreational drugs. Prior to admission, he
developed an acute AD flare-up that was poorly controlled.
On presentation, he was pyrexial at 38.9◦C with a blood pres-
sure of 128/84 mmHg, respiratory rate of 20 breaths per minute
and heart rate of 100 beats per minute. His AD affected his upper
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Figure 1: Pre-operative echocardiographic images showing tricuspid valve vegetation (a,b,c).
Figure 2: Modified Duke criteria for diagnosing infective endocarditis [6].
and lower limbs as hyperpigmented eczematous areas with
lichenification, excoriation and xerosis with crusted erosion on
the right shin. He had no peripheral stigmata of infective endo-
carditis, but he had a systolic murmur over the tricuspid area.
His electrocardiogram showed sinus tachycardia with a
normal PR interval. C-reactive protein level andwhite cell counts
were raised at 248 mg/L and 14.9×109 cells/L, respectively,
and blood cultures isolated methicillin-sensitive Staphylococcus
aureus (MSSA). An urgent transthoracic echocardiogram (TTE)
showed a large mobile structure (Fig. 1) that appeared to be
attached to the tricuspid valve’s septal leaflet. This mass
prolapsed between the right atrium and right ventricle. There
was mild TV regurgitation, a small patent foramen ovale (PFO)
and good left and right ventricular systolic functions.
He was diagnosed with definitive infective endocarditis
(Fig. 2: meeting all major criteria and minor criteria 2,3)
and MSSA bacteraemia, clinically felt to be attributed to his
dermatitis (Fig. 3). He was urgently referred to the dermatology
team who advised treatment with potent steroid cream,
emollients and antimicrobial washes.
He was started on intravenous 2 g Flucloxacillin four times
daily (QDS). He suddenly developed dyspnoea, chest pain and
haemoptysis.Chest computed tomography (CT) confirmed acute
pulmonary emboli, in keeping with septic emboli and infarcts
(Fig. 4). Anticoagulation was not advised initially due to the risk
of haemorrhagic transformation. Nine days later, Clindamycin
600mgQDSwas added because of ongoing pyrexia. Due to a pos-
itive sputumculture, Flucloxacillinwas escalated toMeropenem.
Surgery was initially delayed because of chest sepsis; how-
ever, because of ongoing pleuritic chest pain and haemoptysis,
it was undertaken on day 17.He underwent tricuspid valve repair
and annuloplasty with a 28-mm Carpentier Edwards physic
annuloplasty ring. The defect in the septal leaflet was closed
directly, and the resultant gap was closed by moving the poste-
rior leaflet onto the septum. This left the new valve functionally
bicuspid (Fig. 5). The vegetation included part of the papillary
muscle that had ruptured. There was a right to left shunt via
the small PFO, which spontaneously closed.
Meropenem was de-escalated to Flucloxacillin 3 days post-
operatively. Repeat echocardiogram showed good valve function,
reasonable left ventricular systolic function, but impaired right
systolic function and mild tricuspid regurgitation. Since post-
operative CRP levels remained static, CT chest was repeated. A
significant increase in embolic burden and infarction was noted,
and a clinical decision was made to start anticoagulation.
Repeat blood cultureswere negative and he remained apyrex-
ial. An echocardiogram, 1 month later, showed improving right
ventricular function. His inpatient stay was complicated by a
subsequent hospital acquired pneumonia and InfluenzaA.Upon
completion of 6weeks of Flucloxacillin and Clindamycin,his CRP
level was 17 mg/L. He was discharged on Apixaban for 3 months
and emollients with local dermatology follow-up.
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Figure 3: Atopic dermatitis, excoriation and erosion in right shin secondary to xerosis and chronic itching (a) and symmetrical lichenification on both feet (b and c).
Figure 4: CT scan showing pulmonary emboli in left and right pulmonary arteries (a,b).
Figure 5: Post-operative echocardiographic images showing repaired tricuspid
valve.
DISCUSSION
Infective endocarditis (IE) is associated with high morbidity; its
in-hospital mortality rate varies from 15 to 30%. The literature
relating atopic dermatitis to IE keeps expanding and yet, patients
are not receiving optimal dermatological treatment and appro-
priate referral [7]. Indeed, Aoyagi et al. [5] identify 24 cases of
infective endocarditis in patients with atopic dermatitis; median
agewas 27.5 years old (similar to our patient), younger compared
to the median age of IE in the general population. Micallef et al.
[3] report a similar case to ours with the mitral valve being
affected, and Tsuboi et al. [8] report a patient with AD having
Staphylococcus aureus bacteraemia complicated by psoas abscess
and IE.
About 5–10% of IE cases are right sided and are most com-
monly seen in intravenous drug users and immunosuppressed
patients. Immunosuppression, the presence of cardiac effects or
previous valvuloplasty are recognised risk factors. Our patient
was healthy beyond the atopic dermatitis, with no history of
recreational drug use. This supports the evidence that AD is an
independent risk factor for IE.
Complications of IE include embolic events, which can occur
in 20–50% of patients. Aoyagi et al. [5] report that 62.5% of
their 24 cases developed embolic events, 50% of which were
cerebral. Our patient developed pulmonary emboli with recur-
rent haemoptysis. The decision to anticoagulate was challeng-
ing, but he was started on therapeutic Dalteparin and then
Apixaban.
Recognising infective endocarditis and its source is essential
for appropriate management. When patients with AD present
with prolonged pyrexia, IE should be ruled out including
metastatic spread, as per Tsuboi et al. [8]
Therefore, we strongly recommend the early involvement of
dermatologists in patients with uncontrolled atopic dermatitis
to achieve optimum control and prevent complications. Topical
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steroids and oral immunosuppressants are established treat-
ments. Dupilumab is a safe and effective biologic treatment for
AD used for refractory cases [9]. Nakanishi et al. [10] support
treatment of AD with Dupilumab 2 months before elective car-
diac surgery for a case of IE. It is also important to educate
patients to seek medical attention when their skin condition
flares up. Early use of antibiotics for active infections or prophy-
lactic antimicrobial washes could potentially be considered.
SUPPLEMENTARY MATERIAL
Supplementary material is available at the Oxford Journal of Med-
ical Case Reports online.
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